Related Experiment Videos
Minnesota Resuscitation Consortium's Advanced Perfusion and Reperfusion Cardiac Life Support Strategy for
Demetris Yannopoulos1, Jason A Bartos2, Cindy Martin2
1Division of Cardiology, Department of Medicine, University of Minnesota School of Medicine, Minneapolis, MN yanno001@umn.edu.
Journal of the American Heart Association
|July 15, 2016
Summary
The Minnesota Resuscitation Consortium
Area of Science:
- Cardiology
- Emergency Medicine
- Critical Care Medicine
Background:
- The Minnesota Resuscitation Consortium (MRC) introduced an advanced life support strategy in 2015.
- This strategy focuses on perfusion and reperfusion for patients experiencing out-of-hospital refractory ventricular fibrillation/ventricular tachycardia (VF/VT).
Purpose of the Study:
- To evaluate the initial outcomes of the MRC's advanced perfusion and reperfusion life support strategy.
- To assess the feasibility and effectiveness of this protocol in improving survival rates for refractory VF/VT.
Main Methods:
- Three emergency medical services systems in the Minneapolis-St. Paul metro area participated.
- Patients aged 18-75 with refractory VF/VT, meeting specific inclusion/exclusion criteria, were transported for advanced interventions.
- Interventions included mechanical cardiopulmonary resuscitation (CPR), extracorporeal membrane oxygenation (ECMO), coronary angiography, and percutaneous coronary intervention (PCI).
Main Results:
- Of 27 patients transported, 18 met the study criteria.
- 83% received ECMO, and 67% underwent PCI for complex coronary artery disease.
- Survival to hospital discharge was 55%, with 50% achieving good neurological function.
Conclusions:
- The MRC refractory VF/VT protocol is feasible to implement.
- This strategy resulted in a high rate of functionally favorable survival with minimal complications.